HomeOpen Access NewsDiseases & Conditions

Diseases & Conditions

UK’s first citizen‑led lead exposure screening in children launches in Leeds

A pioneering study, the Elevated Childhood Lead Interagency Prevalence Study (ECLIPS), has launched in Leeds to screen children aged 1–6 for lead exposure using home-based finger‑prick blood tests, soil and dust sampling, and surveys.

New tool predicts Alzheimer’s risk years before symptoms

Researchers at Mayo Clinic have created a new prediction model combining age, sex, genetic markers, and brain amyloid levels to estimate an individual's lifetime risk of Alzheimer's or mild cognitive impairment,

UK provides £15.9 million to transform human disease modelling

A new UK research initiative is set to revolutionise how scientists study human diseases and develop new medicines.

Workplace challenges affect 40% of employees living with diabetes

A global survey by the International Diabetes Federation shows that 40 % of employees with diabetes face negative treatment at work, with many considering leaving their jobs due to stigma and lack of support.

UK trial launches blood test to improve dementia diagnosis at scale

A major trial led by the University of Bristol and North Bristol NHS Trust is exploring a panel of blood tests to detect dementia faster and more accurately across diverse UK populations.

Breakthrough stem cell therapy sparks powerful bone regeneration in spinal fractures

Scientists at Osaka Metropolitan University have unlocked a new way to regenerate bone using fat-derived stem cells, successfully healing spinal fractures in rats.

Wearable brain‑imaging tech reveals new insights into multiple sclerosis

Researchers at the University of Nottingham have used a lightweight, wearable OPM‑MEG brain scanner to uncover distinct brain‐function changes in people with Multiple Sclerosis, a non‑invasive advance that could improve diagnosis and tracking of disease progression.

MHRA to fast-track rare disease treatments in major reform

The Medicines and Healthcare products Regulatory Agency (MHRA) has published a new framework signalling a significant overhaul of how rare disease treatments are tested, approved, and delivered in the UK.

World Psoriasis Day: Advancing early detection of psoriatic arthritis through iPROLEPSIS

Every year on 29 October, World Psoriasis Day raises awareness of the 125 million people worldwide living with psoriasis and psoriatic arthritis (PsA).

Scientists reveal the exact moment your brain switches off to sleep

Breakthrough research shows the brain doesn't drift into sleep gradually; it hits a sudden "tipping point." Discover how scientists pinpoint the second your brain shuts down each night.

UK’s first MS patient receives CAR T-cell therapy in landmark trial

A UK patient has become the first with multiple sclerosis (MS) to receive cutting-edge CAR T-cell therapy, as scientists test whether the one-time treatment can halt disease progression.

Canada’s youth facing growing opioid crisis: Calls for urgent action

Explore the rising youth involvement in the Canada opioid crisis and the urgent need for effective interventions and support.

From ‘analogue to digital’: Will digital transformation improve HIV care?

Last month, the UK Government published its long-awaited 10-Year Health Plan, with one of its three key shifts being the move from ‘analogue to digital’.

MS may start years before symptoms, UCSF study reveals

UCSF researchers found early immune signs of multiple sclerosis years before symptoms, a discovery that could transform diagnosis and care.

Largest-ever £26 million trial launches across UK to slow Parkinson’s disease

The world's largest clinical trial for Parkinson’s disease has commenced, aiming to identify treatments that can slow or halt disease progression.

Seven AI tools selected for MHRA’s AI Airlock programme to detect diseases early

Seven AI technologies have been chosen for the next phase of the MHRA’s AI Airlock programme, aiming to improve early detection of diseases.

Faster MRI scans could make early dementia diagnosis more accessible

Researchers at UCL have developed a method to reduce MRI scan times for dementia diagnosis by two-thirds, potentially doubling daily scan capacity and improving access to early care.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders